Creekmur Asset Management LLC Sells 167 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Creekmur Asset Management LLC lessened its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 9.0% in the fourth quarter, HoldingsChannel reports. The fund owned 1,687 shares of the medical equipment provider’s stock after selling 167 shares during the period. Creekmur Asset Management LLC’s holdings in Intuitive Surgical were worth $881,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Atala Financial Inc purchased a new stake in shares of Intuitive Surgical during the fourth quarter valued at approximately $25,000. Berbice Capital Management LLC purchased a new stake in Intuitive Surgical during the 4th quarter valued at $26,000. BankPlus Trust Department bought a new stake in Intuitive Surgical in the 4th quarter worth $28,000. Summit Securities Group LLC purchased a new position in shares of Intuitive Surgical in the fourth quarter valued at about $30,000. Finally, Kohmann Bosshard Financial Services LLC bought a new position in shares of Intuitive Surgical during the fourth quarter valued at about $31,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on ISRG. UBS Group boosted their price target on Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a report on Monday, January 27th. Robert W. Baird decreased their target price on Intuitive Surgical from $707.00 to $600.00 and set an “outperform” rating for the company in a report on Tuesday, March 18th. Stifel Nicolaus lifted their price target on shares of Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a report on Thursday, December 5th. Evercore ISI raised their target price on shares of Intuitive Surgical from $490.00 to $530.00 in a research report on Monday, January 27th. Finally, Piper Sandler reissued an “overweight” rating and set a $670.00 price objective (up previously from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have given a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $611.86.

Insider Buying and Selling at Intuitive Surgical

In other news, CFO Jamie Samath sold 269 shares of Intuitive Surgical stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $590.00, for a total value of $158,710.00. Following the sale, the chief financial officer now directly owns 3,282 shares of the company’s stock, valued at approximately $1,936,380. The trade was a 7.58 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Amal M. Johnson sold 4,635 shares of Intuitive Surgical stock in a transaction on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the transaction, the director now directly owns 12,275 shares of the company’s stock, valued at $6,955,015. The trade was a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 33,754 shares of company stock valued at $17,691,621 over the last 90 days. 0.70% of the stock is currently owned by corporate insiders.

Intuitive Surgical Stock Up 0.2 %

ISRG stock opened at $496.36 on Wednesday. The business’s 50-day moving average price is $552.17 and its 200-day moving average price is $533.02. The stock has a market cap of $176.79 billion, a P/E ratio of 77.44, a PEG ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.